Cognoa
About Cognoa
Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable the earlier diagnosis and treatment of behavioral health conditions, such as autism. The company’s AI technology platform will enable Cognoa's product pipeline to address additional unmet needs including ADHD and anxiety. Cognoa plans to commercialize its first product, the first digital autism diagnosis aid, under the name Canvas Dx™ and expects to begin making Canvas Dx™ available in the U.S. later in 2021.